Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-?: a multicenter observational study.
Ontology highlight
ABSTRACT: BACKGROUND:Circulating interferon-? (IFN-?) concentration may be sustained at a high level regardless of the initiation of antiretroviral therapy (ART) in some patients with HIV-1 infection. In the present study, we examined the clinical characteristics of HIV-1-infected patients with high levels of plasma IFN-?. METHODS:The study subjects were patients infected with HIV-1 who were either naïve to ART with CD4+ cell count >?200 cells/?L (n?=?12), or had achieved viral suppression after ART for over a year (n?=?188). The levels of plasma IFN-? and interleukin-6 (IL-6) were measured by the enzyme-linked immunosorbent assay. Patients were divided into high IFN-? and low IFN-? groups based on a cutoff level of 5?pg/mL. RESULTS:The high IFN-? group included 41 patients (21%). Compared to the patients on ART with low IFN-? levels, those on ART in the high IFN-? group were more likely to be younger than 50?years of age (P?=?0.0051) and less likely to have dyslipidemia (P?=?0.0476) or to be on a protease inhibitor (P?=?0.0449). There was no significant difference between groups in the median increase of CD4+ cell counts from the initiation of ART for up to 3?years. However, after 4?years, the increase in CD4+ cell counts was significantly lower in the high IFN-? group compared with that in the low IFN-? group. There were no such significant differences between patients with low and high (>?2?pg/mL) levels of plasma IL-6. CONCLUSION:We concluded that HIV-1-infected patients with high levels of circulating IFN-? did not have a higher rate of comorbidities related to immune activation. However, they exhibited lower CD4+ cell count recovery after 4?years of being on ART. This deficit could be a consequence of persistent immune activation.
SUBMITTER: Watanabe D
PROVIDER: S-EPMC6321664 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA